Science Explorer Back to mapMap
Discussion
Company · Abingdon · United Kingdom

Immunocore (United Kingdom)

immunocore.comROR OpenAlex
World rank, all time
#25,908
of 34,923
Rank in United Kingdom
#1,381
of 1,844
Research works
123
▲ 9% vs 2018-21
Citations
2.5k
20.0 per fractional work
Top-10% rate
9.7%
all institutions 10.0%
vs its own fields
0.95×
1.00× is exactly expected
Open access
56%
world 40%
International
32%
world 18%
Immunocore (United Kingdom)

Which fields of science does Immunocore (United Kingdom) work in?

In 2022-now, 50% of research at Immunocore (United Kingdom) is in Life Sciences, 44% in Health Sciences. Its largest fields are Medicine (43%), Immunology and Microbiology (33%), Biochemistry, Genetics and Molecular Biology (15%). It does 2.9× the world's share of Life Sciences.

Life Sciences: 24 fractional works · 50.1% of its workImmunology and Microbiology: 16 fractional works · 33.3% of its workImmunology: 15 fractional works · 31.7% of its workVirology: 1 fractional works · 1.6% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 15.5% of its workMolecular Biology: 6 fractional works · 12.2% of its workGenetics: 1 fractional works · 1.6% of its workCell Biology: 0 fractional works · 0.9% of its workCancer Research: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.7% of its workPharmaceutical Science: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 0.4% of its workPlant Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 0.2% of its workHealth Sciences: 21 fractional works · 43.6% of its workMedicine: 21 fractional works · 43.4% of its workOncology: 10 fractional works · 21.6% of its workRadiology, Nuclear Medicine and Imaging: 4 fractional works · 7.5% of its workOphthalmology: 3 fractional works · 5.9% of its workEpidemiology: 1 fractional works · 2.1% of its workHematology: 0 fractional works · 0.9% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.9% of its workDermatology: 0 fractional works · 0.7% of its workHepatology: 0 fractional works · 0.7% of its workInfectious Diseases: 0 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workUrology: 0 fractional works · 0.4% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workRehabilitation: 0 fractional works · 0.2% of its workSurgery: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 1.0% of its workHealth Professions: 0 fractional works · 0.2% of its workPhysical Sciences: 3 fractional works · 5.8% of its workEngineering: 2 fractional works · 3.6% of its workBiomedical Engineering: 2 fractional works · 3.6% of its workEnvironmental Science: 0 fractional works · 0.8% of its workEnvironmental Chemistry: 0 fractional works · 0.3% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.6% of its workMaterials Chemistry: 0 fractional works · 0.4% of its workBiomaterials: 0 fractional works · 0.2% of its workChemistry: 0 fractional works · 0.4% of its workSpectroscopy: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 0 fractional works · 0.2% of its workComputational Theory and Mathematics: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.6% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workDecision Sciences: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.1% of its workALL ITS WORKImmunocore(United Kingdom)48fractional works, 2022-now
Life Sciences50%Physical Sciences6%Health Sciences44%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Immunology and Microbiology1633.3%
    2. Biochemistry, Genetics and Molecular Biology715.5%
    3. Pharmacology, Toxicology and Pharmaceutics00.7%
    4. Agricultural and Biological Sciences00.4%
    5. Neuroscience00.2%
    1. Medicine2143.4%
    2. Health Professions00.2%
    1. Engineering23.6%
    2. Environmental Science00.8%
    3. Materials Science00.6%
    4. Chemistry00.4%
    5. Computer Science00.2%
    6. Mathematics00.1%
    1. Economics, Econometrics and Finance00.4%
    2. Decision Sciences00.2%
    3. Psychology00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Immunocore (United Kingdom) specialise in?

Where its research is concentrated relative to its size: Life Sciences takes 3.8× the share of its output that it takes of world research.

  1. Life SciencesDomain · 24.2 works3.8×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.90× its world share, 8 worksBiochemistry, Geneti…Immunology and Microbiology: 33.08× its world share, 16 worksImmunology and Micro…Neuroscience: 0.15× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.91× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.27× its world share, 0 worksChemistryComputer Science: 0.03× its world share, 0 worksComputer ScienceEngineering: 0.24× its world share, 2 worksEngineeringEnvironmental Science: 0.17× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.16× its world share, 0 worksMaterials ScienceMathematics: 0.12× its world share, 0 worksMathematicsHealth Professions: 0.07× its world share, 0 worksHealth ProfessionsMedicine: 2.26× its world share, 21 worksMedicineDecision Sciences: 0.18× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.16× its world share, 0 worksEconomics, Econometr…Psychology: 0.02× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 33.1×. Every wedge is a field page.

All 16 fields, with their numbers
  1. Immunology and Microbiology33.08×16 works
  2. Biochemistry, Genetics and Molecular Biology2.90×8 works
  3. Medicine2.26×21 works
  4. Pharmacology, Toxicology and Pharmaceutics1.91×0 works
  5. Chemistry0.27×0 works
  6. Engineering0.24×2 works
  7. Decision Sciences0.18×0 works
  8. Environmental Science0.17×0 works
  9. Materials Science0.16×0 works
  10. Economics, Econometrics and Finance0.16×0 works
  11. Neuroscience0.15×0 works
  12. Mathematics0.12×0 works
  13. Agricultural and Biological Sciences0.09×0 works
  14. Health Professions0.07×0 works
  15. Computer Science0.03×0 works
  16. Psychology0.02×0 works

Who are the top researchers at Immunocore (United Kingdom)?

Ranked on the quality score, Bent K. Jakobsen, Koustubh Ranade and Giovanna Bossi lead among researchers whose main affiliation is Immunocore (United Kingdom).

  1. 1 Bent K. Jakobsen United Kingdom · #166,455 worldwide 12k citations · 184 works
  2. 2 Koustubh Ranade United Kingdom · #192,029 worldwide 5.1k citations · 127 works
  3. 3 Giovanna Bossi United Kingdom · #295,028 worldwide 6.7k citations · 94 works
  4. 4 Jane V. Harper United Kingdom · #354,147 worldwide 3.5k citations · 44 works
  5. 5 Namir J. Hassan United Kingdom · #445,892 worldwide 3.8k citations · 61 works
  6. 6 Tara Mahon United Kingdom · #500,266 worldwide 2.4k citations · 34 works
  7. 7 Annelise Vuidepot United Kingdom · #552,866 worldwide 3.1k citations · 60 works
  8. 8 Linda Hibbert United Kingdom · #656,079 worldwide 3.9k citations · 32 works
  9. 9 Peter E. Molloy United Kingdom · #678,456 worldwide 2.2k citations · 37 works
  10. 10 Joseph D. Dukes United Kingdom · #678,849 worldwide 2.8k citations · 42 works
All ranked researchers at Immunocore (United Kingdom)

What are the most cited papers from Immunocore (United Kingdom)?

The most cited paper from Immunocore (United Kingdom) is "Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma" (Gerald P. Linette et al., 2013), with 1,200 citations. Next come "Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma" (916) and "Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells" (700).

Most cited papers
#PaperReleasedCitations
1 Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma Gerald P. Linette et al. · Blood Open access 14 Jun 2013 1,200
2 Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma Paul Nathan et al. · New England Journal of Medicine Open access 22 Sep 2021 916
3 Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells Brian Cameron et al. · Science Translational Medicine Open access 7 Aug 2013 700
4 VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium Dmitry V. Bagaev, Renske M. A. Vroomans, Jerome Samir et al. · Nucleic Acids Research Open access 30 Sep 2019 442
5 Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma Sandra P. D’Angelo, Jeffery Scott Russell, Célèste Lebbé et al. · JAMA Oncology Open access 22 Mar 2018 376
All 60 most cited papers, with filters and sorting

Which keywords describe research at Immunocore (United Kingdom)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Antigen Presentation, Lymphoma, Tumor Regression, CAR T Cells, Chimeric Antigen Receptor and Dendritic Cells.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 37 words, with their numbers
  1. Cancer Immunotherapy12▲ 169×3 topics
  2. Antigen Presentation7▲ 170×2 topics
  3. Immunotherapy7▲ 21×8 topics
  4. CAR T Cells6▲ 184×1 topic
  5. Chimeric Antigen Receptor6▲ 184×1 topic
  6. Lymphoma6▲ 84×2 topics
  7. Tumor Regression6▲ 120×2 topics
  8. Dendritic Cells6▲ 146×2 topics
  9. Immunity6▲ 32×2 topics
  10. Tumor Antigen6▲ 198×1 topic
  11. Vaccine Adjuvants6▲ 198×1 topic
  12. Autoimmunity4▲ 60×3 topics
  13. Foxp34▲ 241×1 topic
  14. TGF-ß4▲ 51×1 topic
  15. Monoclonal Antibodies4▲ 88×3 topics
  16. NK Cell Recognition4▲ 124×1 topic
  17. Natural Killer Cells4▲ 124×1 topic
  18. Tumor Microenvironment4▲ 17×4 topics
  19. Genetic Mutations3▲ 16×4 topics
  20. Therapeutic Antibodies3▲ 99×2 topics
  21. Glycosylation3▲ 60×2 topics
  22. Immune Checkpoint Blockade3▲ 57×1 topic
  23. PD-1 and PD-L13▲ 57×1 topic
  24. Antibody Engineering3▲ 118×1 topic
  25. Fc Receptors3▲ 118×1 topic
  26. Prognostic Factors3▲ 14×3 topics
  27. Retinoblastoma3▲ 388×1 topic
  28. Uveal Melanoma3▲ 388×1 topic
  29. Immune Response2▲ 9.3×9 topics
  30. Cancer Therapy2▲ 6.5×6 topics
  31. Epitope Prediction2▲ 112×1 topic
  32. Peptide-MHC Binding2▲ 112×1 topic
  33. Inflammation2▲ 1.43×7 topics
  34. Antiviral Therapy1▲ 25×3 topics
  35. Cancer1▲ 1.62×6 topics
  36. Epidemiology1▼ 0.59×8 topics
  37. Vaccine1▲ 5.9×4 topics

Which research topics does Immunocore (United Kingdom) publish most on?

By volume in 2022-now: CAR-T cell therapy research, Immunotherapy and Immune Responses, T-cell and B-cell Immunology and Immune Cell Function and Interaction.

CAR-T cell therapy research: 6 fractional worksImmunotherapy and Immune Responses: 6 fractional worksT-cell and B-cell Immunology: 4 fractional worksImmune Cell Function and…4Immune Cell Function and Interaction: 4 fractional worksCancer Immunotherapy and…3Cancer Immunotherapy and Biomarkers: 3 fractional worksMonoclonal and Polyclonal Antibodies Research: 3 fractional worksOcular Oncology and Treatments: 3 fractional worksvaccines and immunoinformatics approaches: 2 fractional worksHIV Research and Treatment: 1 fractional worksNanoplatforms for cancer theranostics: 1 fractional works
OncologyImmunologyRadiology, Nuclear Medicine and ImagingOphthalmology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 6 works
  2. 2 Immunotherapy and Immune Responses Immunology 6 works
  3. 3 T-cell and B-cell Immunology Immunology 4 works
  4. 4 Immune Cell Function and Interaction Immunology 4 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 3 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
  7. 7 Ocular Oncology and Treatments Ophthalmology 3 works
  8. 8 vaccines and immunoinformatics approaches Molecular Biology 2 works
  9. 9 HIV Research and Treatment Virology 1 works
  10. 10 Nanoplatforms for cancer theranostics Biomedical Engineering 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available56.3%not open43.7%

World: 40% of research is openly available.

with international co-authors32.5%domestic only67.5%

World: 18% is written across borders.

How has Immunocore (United Kingdom)'s research output changed?

Output in 2022-2025 was 9% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Immunocore (United Kingdom) as a percentage of every work published that year, 0.00023% in 2024.

still counting0.00020%0.00040%Immunocore (United Kingdom)0.00014% in 20251990200020102020

Fractional works of Immunocore (United Kingdom) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Abingdon

All research institutions in Abingdon

Share Immunocore (United Kingdom)'s ranking

Immunocore (United Kingdom) on Science Explorer

A card with Immunocore (United Kingdom)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Immunocore (United Kingdom). Posts are plain text and can be reported.